Alnylam Competitors and Similar CompaniesClear all

Alnylam's competitors and similar companies include Celyad, Sorrento Therapeutics, Moderna, Regulus Therapeutics, Sarepta Therapeutics and Ionis Pharmaceuticals.
Alnylam
Alnylam
Alnylam is a biopharmaceutical company that develops ribonucleic acid interference (RNAi) therapeutics for hepatic porphyria, primary hyperoxaluria type 1 (PH1), cardiovascular, and polyneuropathy treatments.
Celyad
Celyad
Celyad is a biopharmaceutical company focused on the discovery and development of regenerative and protective therapies in cardiology and oncology.
Sorrento Therapeutics
Sorrento Therapeutics
Sorrento Therapeutics is focused on the development of proprietary drug therapeutics for addressing unmet medical needs.
Moderna
Moderna
Moderna (formerly Moderna Therapeutics) is a biotechnology company focused on messenger RNA (mRNA) medicine.
Regulus Therapeutics
Regulus Therapeutics
Regulus Therapeutics is a biopharmaceutical company involved in the R&D of high-impact medicines based on microRNAs.
Sarepta Therapeutics
Sarepta Therapeutics
Sarepta Therapeutics is a biopharmaceutical company specializing in the discovery and development of RNA-targeted therapeutics, gene therapy and, other genetic therapeutic modalities for the treatment of rare diseases.
Ionis Pharmaceuticals
Ionis Pharmaceuticals
Ionis Pharmaceuticals (formerly known as Isis Pharmaceuticals) is a company that discovers and develops RNA-targeted therapeutics.
Founding Date
Founding Date
2002
Founding Date
2007
Founding Date
2006
Founding Date
2010
Founding Date
2007
Founding Date
1980
Founding Date
1989
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Cambridge, US HQ
Paris, FR
Milan, IT
Tokyo, JP
Amsterdam, NL
Stockholm, SE
Zug, CH
see more
Locations
Mont-Saint-Guibert, BE HQ
New York, US
Locations
San Diego, US HQ
San Diego, US
Locations
Cambridge, US HQ
Melbourne, AU
Paris, FR
München, DE
Tokyo, JP
Seoul, KR
Warszawa, PL
see more
Locations
San Diego, US HQ
Locations
Cambridge, US HQ
Dublin, IE
Zug, CH
Providence, US
Locations
Carlsbad, US HQ
Employees
Employees
1,32324% increase
Employees
1751% decrease
Employees
31019% decrease
Employees
5,60044% increase
Employees
2462% decrease
Employees
1,31413% increase
Employees
92716% increase
Valuation ($)
Valuation ($)
35.3 b
Valuation ($)
N/A
Valuation ($)
2.2 m
Valuation ($)
25.7 b
Valuation ($)
105.4 m
Valuation ($)
11.9 b
Valuation ($)
6.5 b

Financial

Revenue (est.)
Revenue (est.)
$1.8b (FY, 2023)
Revenue (est.)
€102k (FY, 2023)
Revenue (est.)
$62.8m (FY, 2022)
Revenue (est.)
$6.8b (FY, 2023)
Revenue (est.)
N/A
Revenue (est.)
$1.2b (FY, 2023)
Revenue (est.)
$787.6m (FY, 2023)
Cost of goods
Cost of goods
$268.2m (FY, 2023)
Cost of goods
€69k (FY, 2023)
Cost of goods
N/A
Cost of goods
$4.7b (FY, 2023)
Cost of goods
N/A
Cost of goods
$150.3m (FY, 2023)
Cost of goods
$9.1m (FY, 2023)
Gross profit
Gross profit
$1.6b (FY, 2023)
Gross profit
€1.4m (FY, 2023)
Gross profit
N/A
Gross profit
$2.2b (FY, 2023)
Gross profit
N/A
Gross profit
$1.1b (FY, 2023)
Gross profit
$778.5m (FY, 2023)
Net income
Net income
($440.2m) (FY, 2023)
Net income
(€8.4m) (FY, 2023)
Net income
($577.8m) (FY, 2022)
Net income
($4.7b) (FY, 2023)
Net income
($30m) (FY, 2023)
Net income
($536m) (FY, 2023)
Net income
($366.3m) (FY, 2023)

Operating

Patents Issued
Patents Issued
N/A
Patents Issued
N/A
Patents Issued
N/A
Patents Issued
270 (FY, 2020)
Patents Issued
300 (FY, 2016)
Patents Issued
N/A
Patents Issued
N/A

Funding

Total funding raised
Total funding raised
$ 1.5b
Total funding raised
N/A
Total funding raised
$ 42.6m
Total funding raised
$ 1.8b
Total funding raised
$ 10m
Total funding raised
N/A
Total funding raised
N/A
For sources of this data, please see the company profile

View Company Profiles

Celyad
HQ
Mont-Saint-Guibert, BE
Employees
17

Celyad is a biopharmaceutical company focused on the discovery and development of regenerative and protective therapies in cardiology and oncology.

View company
Sorrento Therapeutics
HQ
San Diego, US
Employees
310↓ 19% decrease

Sorrento Therapeutics is focused on the development of proprietary drug therapeutics for addressing unmet medical needs.

View company
Moderna
HQ
Cambridge, US
Employees
5,600↑ 44% increase

Moderna (formerly Moderna Therapeutics) is a biotechnology company focused on messenger RNA (mRNA) medicine.

View company
Regulus Therapeutics
HQ
San Diego, US
Employees
24

Regulus Therapeutics is a biopharmaceutical company involved in the R&D of high-impact medicines based on microRNAs.

View company